Which came closer to its stated multiple, CURE or XLVX?

Over the window to Sep 30, 2026, CURE finished 4.1 points from what its multiple implies and XLVX finished 2.1 points from its own, so XLVX came closer. Neither figure predicts the next window: it depends on how much the underlying moves about.

Are CURE and XLVX levered on the same thing?

Yes. Both are levered on health care, CURE at +3 times and XLVX at +2 times the daily move.

Which one decays faster, CURE or XLVX?

Decay follows how much the underlying moves about. Over this window CURE’s moved at 18% annualized and XLVX’s at 18%, so CURE has the rougher ride and, at the same multiple, loses more to compounding.

Can I hold CURE or XLVX for a year?

Both reset every day, so the multiple in the name applies to a single day and the daily results compound. Over a year the total is not the multiple times the year’s move, and in a market that falls and comes back it is reliably less. ETFIQ makes no recommendation either way.

Which is cheaper, CURE or XLVX?

CURE charges 0.94% a year and XLVX charges 0.45%, so XLVX is cheaper. Fees come from each fund's prospectus.

Share on X Download as PDF Open live

CURE vs XLVX: which held to its multiple?

Over three months against its own daily promise, CURE finished 2.5 points short and XLVX 1.6 points short. Direxion Daily Healthcare Bull 3X ETF and Corgi U.S. Healthcare 2x Daily ETF.

+13.8%

CURE returned, 3 months

+9.8%

XLVX returned, 3 months

−4.1 pts

CURE from its stated multiple

−2.1 pts

XLVX from its stated multiple

CURE · 3 months to Sep 30, 20264.1 pts short of its stated multiple

CURE returned +13.8% while 3 times XLV's move would have been +17.9%

XLVX · 3 months to Sep 30, 20262.1 pts short of its stated multiple

XLVX returned +9.8% while 2 times XLV's move would have been +11.9%

ETFIQ Decay Resistance Score · XLVX scores higherDid it keep up with its own daily multiple, compounded day by day?

CURE 55.4

XLVX 82.7

0.1, the lowest in this set99.9, the highest

A percentile among the 470 leveraged ETFs, long, over three months. It is a position in a set, not a rating, and neither end of it is a recommendation. All leveraged ETFs ranked by it → How it is computed →

Performance, window by window

	Total return		Multiple would give		Difference
Window	CURE	XLVX	CURE	XLVX	CURE	XLVX
1 month	−3.6%	−2.2%	−2.6%	−1.7%	−1.0 pts	−0.5 pts
3 months	+13.8%	+9.8%	+17.9%	+11.9%	−4.1 pts	−2.1 pts
6 months	+38.8%	not published	+44.8%	not published	−6.0 pts	not published
1 year	+56.9%	not published	+69.1%	not published	−12.2 pts	not published
3 years	+51.9%	not published	+112.5%	not published	−60.6 pts	not published
Since launch CURE Jun 2011 · XLVX Jun 2026	+2815.8%	+28.2%	not meaningful	+30.2%	not meaningful	−2.0 pts

CURE and XLVX over each window. Every figure is an ETFIQ calculation with distributions reinvested. Source: ETFIQ. Open the live comparison on ETFIQ →

On the same fields

CURE

Direxion Daily Healthcare Bull 3X ETF · Aims to return three times the daily move of health care (XLV)

XLVX

Corgi U.S. Healthcare 2x Daily ETF · Aims to return twice the daily move of health care (XLV)

Issuer Direxion Corgi

Sets out to return +3x +2x

Underlying asset XLV XLV

Segment sector sector

Fund returned, 3 months or since launch +13.8% +9.8%

Underlying returned, over that window +6.0% +6.0%

What the stated multiple implies, over that window +17.9% +11.9%

Difference from stated, over that window −4.1 pts −2.1 pts

Fund returned, 1 year or since launch +56.9% +28.2%

Difference from stated, over that window −12.2 pts −2.0 pts

Underlying volatility 18% 18%

Difference over the days both have traded no shared window −2.1 pts

Expense ratio 0.94% 0.45%

Launched Jun 15, 2011 Jun 3, 2026

Net assets $168m $647,180

CURE and XLVX on the same fields, as of Sep 30, 2026. Source: ETFIQ.

CURE in plain words

Three months to Sep 30, 2026: CURE returned +13.8% where its own daily promise gave +16.3%, 2.5 points short. Read the multiple against the whole window instead and 3 times XLV's 6.0% implies +17.9%, which makes CURE look 4.1 points short. 1.6 of that is daily compounding, which happens to any 3 times fund over the same path, and the rest is the fund. CURE aims to return +3 times XLV's move each day, then resets. Over one day it does that. Over longer, the daily results compound, so the total is not +3 times the period's move: in a market that falls and comes back it is reliably less, and in a steady run it can be more. XLV moved at 18% annualized over that window. That is what decides how far the two figures separate: the same fund on a calm underlying and a violent one is a different product.

XLVX in plain words

Three months to Sep 30, 2026: XLVX returned +9.8% where its own daily promise gave +11.4%, 1.6 points short. Read the multiple against the whole window instead and 2 times XLV's 6.0% implies +11.9%, which makes XLVX look 2.1 points short. 0.5 of that is daily compounding, which happens to any 2 times fund over the same path, and the rest is the fund. XLVX aims to return +2 times XLV's move each day, then resets. Over longer, the daily results compound, so the total is not +2 times the period's move: in a market that falls and comes back it is reliably less, and in a steady run it can be more.

Questions people ask

Which came closer to its stated multiple, CURE or XLVX?: Over the window to Sep 30, 2026, CURE finished 4.1 points from what its multiple implies and XLVX finished 2.1 points from its own, so XLVX came closer. Neither figure predicts the next window: it depends on how much the underlying moves about.
Are CURE and XLVX levered on the same thing?: Yes. Both are levered on health care, CURE at +3 times and XLVX at +2 times the daily move.
Which one decays faster, CURE or XLVX?: Decay follows how much the underlying moves about. Over this window CURE’s moved at 18% annualized and XLVX’s at 18%, so CURE has the rougher ride and, at the same multiple, loses more to compounding.
Can I hold CURE or XLVX for a year?: Both reset every day, so the multiple in the name applies to a single day and the daily results compound. Over a year the total is not the multiple times the year’s move, and in a market that falls and comes back it is reliably less. ETFIQ makes no recommendation either way.
Which is cheaper, CURE or XLVX?: CURE charges 0.94% a year and XLVX charges 0.45%, so XLVX is cheaper. Fees come from each fund's prospectus.

Other comparisons

CURE vs RXD CURE vs RXL XLVX vs RXD XLVX vs RXL

XLV →CURE on its own →XLVX on its own →How every figure is computed →Standards and sources →

Where these figures came from

CURE filings on SEC EDGAR ↗CURE prospectus with the expense ratio (SEC) ↗Direxion website ↗XLVX filings on SEC EDGAR ↗XLVX prospectus with the expense ratio (SEC) ↗Corgi website ↗

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement. A comparison is not a recommendation.

Cite this page

ETFIQ, CURE against XLVX, data as of Sep 30, 2026. https://etfiq.com/compare/leverage/cure-vs-xlvx

Open data

Free to use with attribution. Every figure is calculated from a named public source; the method is at etfiq.com/methodology.